Eli Lilly, a prominent player in the pharmaceutical industry, has recently taken significant steps to expand the availability of its weight loss drug, Zepbound. Facing surging demand, especially among patients without insurance coverage for the medication, the company has introduced higher doses in single-dose vials at reduced prices. This move aims to ensure more patients
Business
In a recent interview with CNBC’s Leslie Picker, Jamie Dimon, the CEO of JPMorgan Chase, expressed serious concerns regarding the efficiency and competence of the U.S. government. His remarks come in the wake of the Trump administration’s sweeping efforts to reform federal operations, including the dismissal of thousands of federal employees and the dismantling of
UnitedHealthcare, the largest private health insurer in the United States, finds itself embroiled in a storm of controversies and financial challenges. Recent revelations regarding a government investigation into its Medicare billing practices, the company’s moves towards employee buyouts and potential layoffs, as well as a public spat with billionaire investor Bill Ackman, underscore a year
The journey of Novo Nordisk’s pivotal medications, Wegovy and Ozempic, represents a significant chapter in the evolving landscape of diabetes treatments and weight management drugs. Recently, the U.S. Food and Drug Administration (FDA) announced that the two-year-long shortage of these important injectable medications has finally been resolved. This development is set against the backdrop of
In a dramatic turn of events, Bluebird Bio has agreed to sell itself to private equity firms Carlyle and SK Capital for approximately $30 million. This sale marks a significant decline for Bluebird, which once held significant promise in the biotech sector but has now succumbed to a series of setbacks, both operationally and financially.
The iconic Boeing 747s, set to serve as the new Air Force One, have become a symbol of both anticipation and frustration for President Donald Trump. The prolonged delivery of these aircraft not only highlights the intricate challenges facing Boeing but also intersects with Trump’s broader political narrative. In light of recent developments, the situation
In a significant organizational shift, KFC, the beloved fried chicken chain, is leaving its historical roots in Louisville, Kentucky, to establish its new U.S. headquarters in Plano, Texas. This decision, announced by parent company Yum Brands, has far-reaching implications not just for the company, but also for the broader fast-food landscape. Roughly 100 employees from
For many individuals diagnosed with sickle cell disease, life is marked by a series of challenges, both physical and emotional. Deshawn “DJ” Chow, a young man whose battle with the disorder began in his early teens, epitomizes the struggle many endure. DJ’s experiences of severe pain that interrupted his education and everyday life highlight the
In a strategic move aimed at enhancing its presence in the female activewear market, Nike has announced a partnership with Skims, the lingerie and shapewear brand founded by Kim Kardashian. This collaboration, titled NikeSKIMS, aspires to create a fresh line of activewear, catering specifically to women and positioning itself against prominent competitors such as Lululemon,
Moderna Inc. has recently reported its fourth-quarter earnings, unveiling a reality that reflects ongoing struggles as the company adapts to a significantly altered market landscape. With growing pains underscored by falling revenues and increasing losses, Moderna’s efforts to diversify and reduce costs are crucial as it seeks to recover from the once-formidable revenue stream generated